Molina因下调2025年全年盈利指引而下跌

2025-10-23 05:04

Molina Healthcare (NYSE:MOH) is down ~18% in after-hours trading Wednesday as it significantly reduced its EPS guidance for 2025.
The health insurer is now projecting non-GAAP EPS of $14, down from a "no less than $19" estimate made in July with its Q2 financial results. Consensus is $18.62.
Molina attributed the guidance cut to higher medical cost trend in all segments, which is disproportionately being felt in its marketplace business. Overall, it sees a 91.3% medical cost ratio ("MCR") for 2025. In July, the company projected it at 90.2%
Q4 non-GAAP EPS guidance has also been changed to $0.35. While Medicaid is expected to contribute $3.00 per diluted share, its is projected to be offset by a loss of $2.65 per diluted share in the Medicare and marketplace segments. Consensus is $3.20.
In Q3, Molina beat on the top line but missed on the bottom.
The insurer was hurt by a higher MCR in the quarter of 92.6% compared to 89.2% in the year-ago period.
Non-GAAP net income fell to $1.84 per share from $6.01 in Q3 2024.

More on Molina Healthcare